- World Pharma News Home » Published News » Financial
-
Sort by:
Recently Popular |
Top Today |
Yesterday |
Week |
Month |
Year |
(a free service delivered by FeedBurner)
Genzyme Corporation (NASDAQ: GENZ) has announced that third-quarter revenue rose 21 percent to $1.160 billion, compared with revenue of $960.2 million in the same period a year ago. The increase was
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Matthew Holt and Indu Subaiya are the chief organizers of the Health 2.0 Connecting Consumers and Providers conference which will take place March 3-
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Sales by the Roche Group in the first nine months of 2008 increased by 6% in local currencies (-2% in Swiss francs; 13% in US dollars) to 33.3 billion Swiss francs. Excluding Tamiflu pandemic sales t
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca PLC has reported that sales in the third quarter increased by 3 percent at CER, or 9 percent on an as reported basis. Sales in the US were unchanged, as the $141 million decline in sales
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
GlaxoSmithKline [LSE/NYSE: GSK] and Genelabs Technologies, Inc. [NASDAQ: GNLB] have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for approximately $57 million (£35
read more » Discuss Add this link to... Bury
Genzyme Corp. (Nasdaq: GENZ) and Osiris Therapeutics (Nasdaq: OSIR) have entered a strategic alliance for the development and commercialization of Prochymal and Chondrogen, two novel, late-stage adul
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The Japanese pharmaceutical company DAIICHI SANKYO Group has purchased the European rights to the osteoporosis medication EVISTA® from the U.S. Company Eli Lilly and Company. In the process, the comp
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The US giant is seeking to recoup $350m (£175m) from Marubeni over loans given through Marubeni to a now bankrupt medical company called Asclepius.
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Roche's Annual General Meeting, which was held today in Basel, has approved all the Board of Directors' proposals. The 662 shareholders in attendance, representing 143,480,308, or 89.7% of a total
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Pfizer held its analyst day yesterday and the stock closed at a new multi-year low. This morning the shares are under a little bit of pressure again as analyst reaction to the event pours in.
In a
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
